Africa Western and Central vs Russia: Immunization, measles second dose
Africa Western and Central
46.9%
in 2024
Russia
93.0%
in 2024
Africa Western and Central rank
43rd
Russia rank
45th
Immunization, measles second dose over time
- Africa Western and Central
- Russia
How they compare
Russia currently reports 93.0% against 46.9% in Africa Western and Central, a difference of 46.1%.
That makes Russia's figure about 2.0 times Africa Western and Central's.
Across all 25 years both countries report, Russia has been ahead every year.
Africa Western and Central ranks 43rd and Russia ranks 45th of 43 groups.
Russia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa Western and Central | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 94.5% | 94.5% | Russia |
| 2010s | 8.3% | 97.1% | 88.8% | Russia |
| 2020s | 39.0% | 95.4% | 56.4% | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Africa Western and Central or Russia?
- Russia, at 93.0% against 46.9% in Africa Western and Central as of 2024.
- What is the difference in immunization, measles second dose between Africa Western and Central and Russia?
- 46.1%, with Russia ahead.
- How many years of comparable data are there for Africa Western and Central and Russia?
- 25 years are reported by both, from 2000 to 2024.
- How do Africa Western and Central and Russia rank globally for immunization, measles second dose?
- Africa Western and Central ranks 43rd and Russia ranks 45th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.